Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

  • This share is currently suspended. It was suspended at a price of 6.75
  • There is currently no data for DCTA

Trading Update

18 Mar 2021 07:00

RNS Number : 6379S
Directa Plus PLC
18 March 2021
 

 

18 March 2021

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

Directa Plus plc

("Directa" or the "Company", or together with its subsidiaries the "Group")

 

Trading Update

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to provide an update on trading in the first quarter of 2021 ("Q1 2021") and for the financial year ended 31 December 2020 ("FY2020").

 

Trading in Q1 2021 has been strong, with revenues expected to be around €1.8m, up 20 per cent. from the same period in 2020 (€1.5m). The Group expects to announce its audited results for FY2020 in mid-May 2021 and to now report revenues of approximately €6.7m, a further improvement from the previously reported expectation of €6.5m. The Group's current order book stands at approximately €4.3m, which is expected to be delivered over the rest of FY2021 and there is a strong pipeline of opportunities.

 

There have been further positive developments in the Company's partnership with NexTech, as part of which Directa is contributing to the development of Lithium-Sulphur battery technology. Directa recently presented alongside NexTech on a roadshow to meet important potential industrial customers and universities in Italy, including Leonardo, Italdesign, Artemide, Politecnico Milan and Politecnico Turin.

 

In addition, Directa and NexTech have now established a Joint Laboratory in Lomazzo, with the objective of developing new specific grades of G+® graphene nanoplatelets for a next generation of higher performance Lithium-Sulphur (Li-S) batteries. Scientists from both companies are participating in this development. Lithium-Sulphur batteries have significant advantages versus Lithium-Ion batteries including superior energy density, lower costs per watt-hour, a superior safety profile, and a less complex manufacturing process.

 

Progress at the Group's environmental subsidiary, Setcar, continues to be very positive. As part of Setcar's contract with OMV Petrom, a total of c.7,700 cubic metres of emulsion have been treated so far in 2021, recovering c.1,800 tonnes of crude oil. With a treatment rate of c.80 cubic metres per day, the Company expects to treat 8,800 cubic metres of emulsion and recover over 2,000 tonnes of crude oil by the end of Q1 2021.

 

Setcar has a healthy and encouraging pipeline of contract tenders across Europe, including a number of high value tenders, with two in the private oil and gas sector and another in a state infrastructure network. Directa will report progress on sales to the market in due course.

 

A new version of Directa's face mask filter, compliant to surgical standards, has been successfully developed and validated creating further opportunities for the Group. The surgical filter offers the wearer an increased level of protection from viral and bacterial infection. This follows recent testing that proved that G+ graphene is not absorbed by the wearer during use.

 

Elsewhere in the textiles vertical the launch of our new Capsule Cosmic Collection is proving successful. The product portfolio will be enriched with two more sportwear items - a golf polo and a soft shell. The Company is receiving and fulfilling customer orders across the product range

 

This announcement has been approved by Giulio Cesareo, Chief Executive, on behalf of the Company.

 

ENDS

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Pete Lynch

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTJRMBTMTJBTRB
Date   Source Headline
28th May 20267:00 amRNSCancellation - Directa Plus plc
27th Apr 20266:00 pmRNSDirecta Plus
27th Apr 20263:21 pmRNSAppointment of Administrators
14th Apr 20267:00 amRNSUpdate on Funding
13th Apr 20267:43 amRNSUpdate on Further Funding
13th Apr 20267:42 amRNSSuspension - Directa Plus PLC
30th Mar 20267:00 amRNSUpdate on Funding
20th Mar 20267:00 amRNSAIM Rule 17 and Schedule 2(g) update
27th Feb 20267:00 amRNSUpdate on Funding and Board change
7th Jan 20267:00 amRNSFull year trading and operational update
15th Dec 20253:26 pmRNSGrant of 2025 LTIP Awards
24th Sep 20257:00 amRNSHalf Year Report
17th Sep 20257:00 amRNSNotice of interim results presentations
4th Aug 202511:26 amRNSPDMR Dealing
4th Aug 20257:00 amRNSHalf Year Trading Update and Notice of Results
30th Jun 20255:03 pmRNSResult of AGM
19th Jun 20257:00 amRNSDirector/PDMR Shareholding
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
16th Jun 20253:27 pmRNSDirector/PDMR Shareholding
16th Jun 202511:34 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSNotice of Investor Presentation
6th Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20257:00 amRNSFinal Results
28th May 20257:00 amRNSNotice of Results
14th Apr 20257:00 amRNSContract Win
7th Apr 20257:00 amRNSTrading and Operational Update & Notice of Results
10th Feb 20257:00 amRNSSetcar secures a new contract win and a renewal
19th Nov 20247:00 amRNSAppointment of Nominated Adviser and Broker
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNotice of Results
26th Jul 20244:33 pmRNSResult of General Meeting
4th Jul 20242:24 pmRNSNotification of major holdings
2nd Jul 20244:23 pmRNSNotification of major holdings
1st Jul 20243:16 pmRNSNotification of major holdings
28th Jun 20243:09 pmRNSDirectors’ Participation in Fundraising
28th Jun 20242:57 pmRNSHolding(s) in Company
28th Jun 202412:09 pmRNSPosting of Annual Report & Accounts
27th Jun 20243:50 pmRNSResult of AGM & GM
26th Jun 20247:00 amRNSFinal Results
24th Jun 20247:00 amRNSUpdate on Voting & Action to be Taken
12th Jun 20241:06 pmRNSPosting of Circular and Notice of General Meeting
11th Jun 202410:40 amRNSResult of Placing and Subscription
11th Jun 20247:00 amRNSProposed equity raise
3rd Jun 20247:00 amRNSNotice of AGM
29th May 20247:00 amRNSGipave selected for Rome 2025 Jubilee project
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.